CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...
Phase 2
Atlanta, Georgia, United States and 22 other locations
Blood Glucose Testing in poorly controlled subjects with Type 1 Diabetes Mellitus.The main question it aims to answer is:-Whether there is a...
Atlanta, Georgia, United States
blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...
Phase 2
Atlanta, Georgia, United States of America and 26 other locations
placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...
Phase 2
Canton, Georgia, United States and 17 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Atlanta, Georgia, United States and 89 other locations
Diabetes is a disorder of high blood glucose, that tends to get worse; over time, patients need more and more drugs. This pattern is caused ...
Decatur, Georgia, United States
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Sandy Springs, Georgia, United States and 40 other locations
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 day...
Phase 3
Acworth, Georgia, United States and 87 other locations
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....
Phase 3
Atlanta, Georgia, United States of America and 42 other locations
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...
Phase 3
DECATUR, Georgia, United States of America and 78 other locations
Clinical trials
Research sites
Resources
Legal